
Sign up to save your podcasts
Or


We bring on biotech reporter Jonathan Wosen to discuss the NIH's decision to dramatically cut funding for overhead costs paid to research institutions and the potential implications for U.S. biomedical innovation. We also chat with health tech reporter Brittany Trang about the claims that two drug developers, Absci and Generate:Biomedicines, have made about the capabilities of their artificial intelligence technologies, and why some experts are skeptical.
By STAT4.5
309309 ratings
We bring on biotech reporter Jonathan Wosen to discuss the NIH's decision to dramatically cut funding for overhead costs paid to research institutions and the potential implications for U.S. biomedical innovation. We also chat with health tech reporter Brittany Trang about the claims that two drug developers, Absci and Generate:Biomedicines, have made about the capabilities of their artificial intelligence technologies, and why some experts are skeptical.

30,768 Listeners

1,942 Listeners

493 Listeners

9,543 Listeners

6,061 Listeners

388 Listeners

62 Listeners

86 Listeners

34 Listeners

522 Listeners

5,522 Listeners

21 Listeners

50 Listeners

400 Listeners

12 Listeners